HCA Healthcare, Inc. $HCA Shares Sold by Metropolis Capital Ltd

Metropolis Capital Ltd decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 35.9% during the 1st quarter, HoldingsChannel.com reports. The firm owned 308,300 shares of the company’s stock after selling 172,379 shares during the quarter. HCA Healthcare accounts for 4.9% of Metropolis Capital Ltd’s holdings, making the stock its 10th largest position. Metropolis Capital Ltd’s holdings in HCA Healthcare were worth $145,900,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HCA. Pictet Asset Management Holding SA grew its holdings in shares of HCA Healthcare by 31.9% during the 1st quarter. Pictet Asset Management Holding SA now owns 161,028 shares of the company’s stock worth $76,180,000 after purchasing an additional 38,961 shares in the last quarter. Union Bancaire Privee UBP SA grew its holdings in shares of HCA Healthcare by 21.3% in the 1st quarter. Union Bancaire Privee UBP SA now owns 654 shares of the company’s stock worth $309,000 after purchasing an additional 115 shares during the last quarter. Cambient Family Office LLC raised its stake in shares of HCA Healthcare by 25.2% in the first quarter. Cambient Family Office LLC now owns 622 shares of the company’s stock valued at $294,000 after acquiring an additional 125 shares during the last quarter. Merkkuri Wealth Advisors LLC bought a new position in HCA Healthcare in the 1st quarter valued at $43,000. Finally, Louisiana State Employees Retirement System bought a new position in shares of HCA Healthcare in the first quarter valued at about $3,786,000. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Up 1.3%

Shares of NYSE HCA opened at $391.96 on Friday. The business’s 50 day moving average price is $408.56 and its two-hundred day moving average price is $465.33. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a market cap of $86.95 billion, a PE ratio of 13.48, a price-to-earnings-growth ratio of 1.24 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the prior year, the firm earned $6.45 earnings per share. HCA Healthcare’s revenue for the quarter was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 30.07 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

Wall Street Analyst Weigh In

HCA has been the subject of several research analyst reports. Stephens dropped their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sanford C. Bernstein cut their price target on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a research report on Thursday, June 4th. Jefferies Financial Group reissued a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a research note on Friday, April 24th. JPMorgan Chase & Co. reduced their price target on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Finally, Wells Fargo & Company decreased their price objective on HCA Healthcare from $481.00 to $436.00 and set an “equal weight” rating for the company in a report on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $503.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.